PMID- 35601078
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230916
IS  - 1606-6359 (Print)
IS  - 1476-7392 (Electronic)
VI  - 30
IP  - 2
DP  - 2022
TI  - Media coverage about medical benefits of MDMA and ketamine affects perceived 
      likelihood of engaging in recreational use.
PG  - 96-103
LID - 10.1080/16066359.2021.1940972 [doi]
AB  - BACKGROUND: Research on the efficacy of ketamine in treating depression and 
      3,4-methylenedioxymethamphetamine (MDMA) in treating post-traumatic stress 
      disorder have been widely covered by the media. Given recent widespread coverage 
      of the efficacy of these drugs, it is important to determine whether such 
      coverage influences prevalence of recreational use. While longitudinal studies 
      would be most ideal for assessing this, to acquire preliminary data, we tested 
      survey items assessing this potential phenomenon in a population known for high 
      prevalence of use of these drugs. METHOD: Adults entering randomly selected 
      nightclubs in New York City (n = 209) were surveyed about drug use. Questions 
      were included to assess their perceived likelihood of recent media coverage about 
      medical benefits associated with use of ketamine and MDMA affecting their own 
      use. RESULTS: Two-thirds (66.8%) of participants had ever used ecstasy/MDMA and 
      22.6% had ever used ketamine. The plurality of participants reported that media 
      coverage about ketamine (46.1%) and MDMA (39.9%) did not affect their likelihood 
      of using. 10.1% and 21.0% of participants reported increased likelihood of using 
      ketamine and MDMA, respectively. 52.3% of those reporting past-month ketamine use 
      and 6.1% of those reporting no lifetime use reported being more likely to use in 
      response to media coverage about ketamine. 28.6% of those reporting past-month 
      ecstasy use and 5.5% of those reporting no lifetime use reported being more 
      likely to use in response to media coverage about MDMA. DISCUSSION: Media 
      coverage about the medical benefits of ketamine and MDMA might influence specific 
      subsets of people to use.
FAU - Palamar, Joseph J
AU  - Palamar JJ
AUID- ORCID: 0000-0002-8565-9415
AD  - Department of Population Health, New York University Langone Medical Center, New 
      York, NY, USA.
FAU - Le, Austin
AU  - Le A
AD  - Department of Population Health, New York University Langone Medical Center, New 
      York, NY, USA.
AD  - New York University College of Dentistry, New York, NY, USA.
LA  - eng
GR  - R01 DA044207/DA/NIDA NIH HHS/United States
PT  - Journal Article
DEP - 20210624
PL  - England
TA  - Addict Res Theory
JT  - Addiction research & theory
JID - 101122095
PMC - PMC9122108
MID - NIHMS1719765
OTO - NOTNLM
OT  - Ketamine
OT  - MDMA
OT  - club drugs
OT  - intention to use
OT  - media
OT  - nightlife
COIS- Disclosure statement The authors declare no conflict of interest.
EDAT- 2022/05/24 06:00
MHDA- 2022/05/24 06:01
PMCR- 2023/01/01
CRDT- 2022/05/23 04:03
PHST- 2022/05/23 04:03 [entrez]
PHST- 2022/05/24 06:00 [pubmed]
PHST- 2022/05/24 06:01 [medline]
PHST- 2023/01/01 00:00 [pmc-release]
AID - 10.1080/16066359.2021.1940972 [doi]
PST - ppublish
SO  - Addict Res Theory. 2022;30(2):96-103. doi: 10.1080/16066359.2021.1940972. Epub 
      2021 Jun 24.